| Cat. No. |
Product Name |
Effect
|
Purity |
Rare Diseases
|
| HY-112698 |
CA-5f |
|
99.14% |
Unkown |
| HY-108277 |
Ginsenoside F5 |
Inducer |
99.90% |
Unkown |
| HY-W093272 |
Thalidomide-5,6-F |
Inducer |
99.84% |
Unkown |
| HY-132226 |
Desamino lenalidomide-5-F |
|
97.72% |
Unkown |
| HY-124421 |
5F-203 |
Inducer |
98.04% |
Unkown |
| HY-W010811 |
Fmoc-Phe(F5)-OH |
|
99.08% |
Unkown |
| HY-P5367 |
5-FAM-PMDM6 |
|
97.06% |
Unkown |
| HY-R01575 |
hsa-miR-518f-5p mimic |
|
92.38% |
Unkown |
| HY-RI01575 |
hsa-miR-518f-5p inhibitor |
|
99.28% |
Unkown |
| HY-118847 |
Antifungal agent 86 |
Inhibitor |
/ |
Unkown |
| HY-147698 |
ZLHQ-5f |
|
/ |
Unkown |
| HY-185609 |
m7G(2'F)(5')ppp(5')(2'OMeA)pG triammonium |
|
/ |
Unkown |
| HY-D1410 |
DMTr-4'-F-5-Me-U-CED phosphoramidite |
|
/ |
Unkown |
| HY-D1779 |
Fura-5F pentapotassium |
|
/ |
Unkown |
| HY-N8311 |
Goshonoside F5 |
Inhibitor |
/ |
Unkown |
| HY-P11865 |
Ac-ATS010-KE |
Inhibitor |
/ |
Unkown |
| HY-P2579 |
Dafphedyn |
Agonist |
/ |
Unkown |
| HY-P4020 |
2F5 epitope |
|
/ |
Unkown |
| HY-P4025 |
ELDKWA |
|
/ |
Unkown |
| HY-R01575A |
hsa-miR-518f-5p agomir |
|
/ |
Unkown |
| HY-R01604 |
hsa-miR-520f-5p mimic |
|
/ |
Unkown |
| HY-R01604A |
hsa-miR-520f-5p agomir |
|
/ |
Unkown |
| HY-R01684 |
hsa-miR-548f-5p mimic |
|
/ |
Unkown |
| HY-R01684A |
hsa-miR-548f-5p agomir |
|
/ |
Unkown |
| HY-R03052 |
mmu-miR-344f-5p mimic |
|
/ |
Unkown |
| HY-R03052A |
mmu-miR-344f-5p agomir |
|
/ |
Unkown |
| HY-R03177 |
mmu-miR-466f-5p mimic |
|
/ |
Unkown |
| HY-R03177A |
mmu-miR-466f-5p agomir |
|
/ |
Unkown |
| HY-R03468 |
mmu-miR-669f-5p mimic |
|
/ |
Unkown |
| HY-R03468A |
mmu-miR-669f-5p agomir |
|
/ |
Unkown |
| HY-RI01575A |
hsa-miR-518f-5p antagomir |
|
/ |
Unkown |
| HY-RI01604 |
hsa-miR-520f-5p inhibitor |
|
/ |
Unkown |
| HY-RI01604A |
hsa-miR-520f-5p antagomir |
|
/ |
Unkown |
| HY-RI01684 |
hsa-miR-548f-5p inhibitor |
|
/ |
Unkown |
| HY-RI01684A |
hsa-miR-548f-5p antagomir |
|
/ |
Unkown |
| HY-RI03052 |
mmu-miR-344f-5p inhibitor |
|
/ |
Unkown |
| HY-RI03052A |
mmu-miR-344f-5p antagomir |
|
/ |
Unkown |
| HY-RI03177 |
mmu-miR-466f-5p inhibitor |
|
/ |
Unkown |
| HY-RI03177A |
mmu-miR-466f-5p antagomir |
|
/ |
Unkown |
| HY-RI03468 |
mmu-miR-669f-5p inhibitor |
|
/ |
Unkown |
| HY-RI03468A |
mmu-miR-669f-5p antagomir |
|
/ |
Unkown |
| HY-RS04114 |
E2F5 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS04644 |
F5 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS09816 |
OR4F5 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-W124385 |
5,5-Difluoro-1,3-dimethyl-5H-5lambda4,6lambda4-dipyrrolo[1,2-c:2',1'-f][1,3 |
|
/ |
Unkown |
| HY-W877994 |
Thalidomide-6-F-5-pip-CHO |
|
95.0% |
Unkown |
| HY-180495 |
5-MeO-NBpBrT |
|
/ |
Unkown |
| HY-201022 |
5'-O-DMT-2'-F-5-MeO-U-3'-CE Phosphoramidite |
|
/ |
Unkown |
| HY-201028 |
5'-C2-O-DMT-2'-F-5-MeO-U-3'-CE Phosphoramidite |
|
/ |
Unkown |
| HY-R04617 |
mmu-let-7f-5p mimic |
|
/ |
Unkown |
| HY-RS16905 |
F5 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS20723 |
E2f5 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS23347 |
F5 Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS27235 |
E2f5 Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-W453715 |
Thalidomide-4-F,5-Br |
|
99.37% |
Unkown |
| HY-W586320 |
Thalidomide-5-Br,6-F |
|
/ |
Unkown |
| HY-W998241 |
Thalidomide-6-F-5-azetidine-COOH |
|
/ |
Unkown |
| HY-W998242 |
Thalidomide-6-F-5-Pip-COOH |
|
/ |
Unkown |
| HY-W998335 |
(S)-Deoxy-thalidomide-6-F-5-piperazine benzenesulfonate |
|
/ |
Unkown |
| HY-W998346 |
Thalidomide-5-NH2-6-F |
|
/ |
Unkown |